Trevi Therapeutics

1 follower


Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Headquarters

Employees

Links

Org chart

Jennifer Good
Co-Founder, President & CEO

Jennifer Good

Collapse
Thomas Sciascia
Co-Founder, Chief Science Officer
David Clark
Chief Medical Officer
Farrell Simon
Chief Commercial Officer
Katherine Takaki
VP, Global Regulatory Affairs
Katie McManus
Senior Manager, Marketing & Communications
Paula Buckley
VP, Clinical Operations
Pam Nieves
Associate Director, Quality Assurance & Compliance